After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Enliven Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Enliven Therapeutics Inc is $1.22B. A total of 0.45 million shares were traded on the day, compared to an average of 467.77K shares.
In the most recent transaction, Patel Anish sold 6,667 shares of ELVN for 20.10 per share on Oct 07 ’25. After the transaction, the CHIEF OPERATING OFFICER now owns 276,641 company shares. In a previous transaction on Sep 29 ’25, Hohl Benjamin sold 3,250 shares at 20.40 per share. ELVN shares that CHIEF FINANCIAL OFFICER owns now total 23,000.
Among the insiders who sold shares, Lyssikatos Joseph P disposed of 4,000 shares on Sep 26 ’25 at a per-share price of $20.25. This resulted in the CHIEF SCIENTIFIC OFFICER holding 927,688 shares of ELVN after the transaction. In another insider transaction, Kintz Samuel sold 3,700 shares at $20.06 per share on Sep 26 ’25. Company shares held by the PRESIDENT AND CEO now total 915,392.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ELVN has a high of $30.03 and a low of $13.30.
As of this writing, ELVN has an earnings estimate of -$0.44 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of -$0.4 per share and a lower estimate of -$0.48. The company reported an EPS of -$0.48 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ELVN’s latest balance sheet shows that the firm has $110.02M in Cash & Short Term Investments as of fiscal 2021. There were $159.00k in debt and $5.75M in liabilities at the time. Its Book Value Per Share was $8.25, while its Total Shareholder’s Equity was -$42.89M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock.
